Hyperparathyroidism screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m Bot: Removing from Primary care |
||
| (2 intermediate revisions by one other user not shown) | |||
| Line 2: | Line 2: | ||
{{Hyperparathyroidism}} | {{Hyperparathyroidism}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{Anmol}} | ||
==Overview== | ==Overview== | ||
There is insufficient evidence to recommend routine screening for hyperparathyroidism. | |||
==Screening== | ==Screening== | ||
There is insufficient evidence to recommend routine screening for hyperparathyroidism. | |||
==References== | ==References== | ||
| Line 26: | Line 16: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
| |||
[[Category:Disease]] | |||
[[Category:Medicine]] | |||
[[Category:Endocrinology]] | |||
[[Category:Parathyroid disorders]] | |||
[[Category:Up-To-Date]] | |||
Latest revision as of 22:16, 29 July 2020
|
Hyperparathyroidism Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hyperparathyroidism screening On the Web |
|
American Roentgen Ray Society Images of Hyperparathyroidism screening |
|
Risk calculators and risk factors for Hyperparathyroidism screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
Overview
There is insufficient evidence to recommend routine screening for hyperparathyroidism.
Screening
There is insufficient evidence to recommend routine screening for hyperparathyroidism.